Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Corvus Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −6 vs. Q3 2022
- Shares held
- 21.4M
- −731.2K (−3.3%) vs. Q3 2022
- Total value
- $18.2M
- +$76.7K (+0.4%) vs. Q3 2022
- New holders
- 5
- 7 more added
- Sold out
- 11
- 14 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | −1,000−90.9% | Reduced |
| Barclays PLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $17 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 70 | $60 | 0.00% | −184−72.4% | Reduced |
| BNP Paribas Arbitrage, SA | 232 | $197 | 0.00% | +133+134.3% | Added |
| Wells Fargo & Company | 235 | $200 | 0.00% | +6+2.6% | Added |
| TCI Wealth Advisors, Inc. | 500 | $425 | 0.00% | −300−37.5% | Reduced |
| Citadel Advisors LLC | 1,015 | $863 | 0.00% | +1,015 | New |
| JPMorgan Chase & Co | 1,201 | $1.00K | 0.00% | −1,585−56.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,750 | $1.00K | 0.00% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 4,200 | $3.57K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,700 | $4.00K | 0.00% | −17,956−79.3% | Reduced |
| Envestnet Asset Management Inc | 10,500 | $8.93K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 10,550 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,718 | $11.0K | 0.00% | +1,050+9.0% | Added |
| Virtu Financial LLC | 18,758 | $16.0K | 0.00% | +18,758 | New |
| Commerce Bank | 20,000 | $17.0K | 0.00% | +20,000 | New |
| Simplex Trading, LLC | 21,419 | $18.0K | 0.00% | +5,369+33.5% | Added |
| Dimensional Fund Advisors LP | 25,459 | $21.0K | 0.00% | −11,592−31.3% | Reduced |
| LMR Partners LLP | 30,000 | $25.5K | 0.00% | 00.0% | Unchanged |
| Hikari Power Ltd | 49,959 | $42.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 61,668 | $52.4K | 0.00% | +9,442+18.1% | Added |
| Jackson Square Capital, LLC | 63,773 | $54.2K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 72,605 | $61.7K | 0.00% | +33,288+84.7% | Added |
| State Street Corp | 112,603 | $95.7K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 131,771 | $111.0K | 0.00% | −10,389−7.3% | Reduced |
| Bridgeway Capital Management, LLC | 159,300 | $135.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 260,300 | $221.3K | 0.00% | −219,800−45.8% | Reduced |
| Two Sigma Investments, LP | 281,187 | $239.0K | 0.00% | −148,521−34.6% | Reduced |
| Geode Capital Management, LLC | 297,800 | $253.0K | 0.00% | −660−0.2% | Reduced |
| Telemetry Investments, L.L.C. | 390,000 | $332.0K | 0.78% | −132,009−25.3% | Reduced |
| BlackRock Inc. | 490,781 | $417.2K | 0.00% | −12,161−2.4% | Reduced |
| Artal Group S.A. | 500,000 | $425.0K | 0.02% | 00.0% | Unchanged |
| Discovery Capital Management, LLC | 548,727 | $466.4K | 0.07% | +548,727 | New |
| Renaissance Technologies LLC | 648,632 | $551.0K | 0.00% | −326,887−33.5% | Reduced |
| Vanguard Group Inc | 1,260,566 | $1.07M | 0.00% | +660+0.1% | Added |
| BVF Inc | 1,370,947 | $1.17M | 0.05% | 00.0% | Unchanged |
| Millennium Management LLC | 1,899,516 | $1.61M | 0.00% | −365,796−16.1% | Reduced |
| CHI Advisors LLC | 2,384,402 | $2.03M | 0.54% | 00.0% | Unchanged |
| Adams Street Partners LLC | 3,275,616 | $2.78M | 0.93% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,943,654 | $5.90M | 0.11% | 00.0% | Unchanged |
| IFP Advisors, Inc | 24 | – | – | +24 | New |
| Bailard, Inc. | 0 | $0 | 0.00% | −39,998−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,775−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −17,261−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −13,790−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −10,688−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,049−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −526−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −436−100.0% | Sold out |